BioCentury
ARTICLE | Company News

Multiplicom sales and marketing update

August 17, 2015 7:00 AM UTC

Multiplicom launched the CLL MASTR Plus Kit worldwide for research use only to improve diagnosis of patients with chronic lymphocytic leukemia (CLL). The mutation kit identifies mutations tumor prot...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article